JP2025184979A5 - - Google Patents
Info
- Publication number
- JP2025184979A5 JP2025184979A5 JP2025162640A JP2025162640A JP2025184979A5 JP 2025184979 A5 JP2025184979 A5 JP 2025184979A5 JP 2025162640 A JP2025162640 A JP 2025162640A JP 2025162640 A JP2025162640 A JP 2025162640A JP 2025184979 A5 JP2025184979 A5 JP 2025184979A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- sequence
- polypeptide
- vector
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2004826.0 | 2020-04-01 | ||
| GBGB2004826.0A GB202004826D0 (en) | 2020-04-01 | 2020-04-01 | Coronavirus vaccines |
| GBGB2010672.0A GB202010672D0 (en) | 2020-07-10 | 2020-07-10 | Coronovirus vaccines |
| GB2010672.0 | 2020-07-10 | ||
| GBGB2015775.6A GB202015775D0 (en) | 2020-10-05 | 2020-10-05 | Coronavirus vaccines |
| GB2015775.6 | 2020-10-05 | ||
| GB2101824.7 | 2021-02-10 | ||
| GBGB2101824.7A GB202101824D0 (en) | 2021-02-10 | 2021-02-10 | Coronavirus vaccines |
| GB2103214.9 | 2021-03-08 | ||
| GBGB2103214.9A GB202103214D0 (en) | 2021-03-08 | 2021-03-08 | Coronavirus vaccines |
| PCT/GB2021/050830 WO2021198706A2 (en) | 2020-04-01 | 2021-04-01 | Coronavirus vaccines |
| JP2022560285A JP2023522156A (ja) | 2020-04-01 | 2021-04-01 | コロナウイルスワクチン |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560285A Division JP2023522156A (ja) | 2020-04-01 | 2021-04-01 | コロナウイルスワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025184979A JP2025184979A (ja) | 2025-12-18 |
| JP2025184979A5 true JP2025184979A5 (cg-RX-API-DMAC7.html) | 2026-04-16 |
Family
ID=75426636
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560285A Pending JP2023522156A (ja) | 2020-04-01 | 2021-04-01 | コロナウイルスワクチン |
| JP2025162640A Pending JP2025184979A (ja) | 2020-04-01 | 2025-09-29 | コロナウイルスワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560285A Pending JP2023522156A (ja) | 2020-04-01 | 2021-04-01 | コロナウイルスワクチン |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240285751A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4126033A2 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2023522156A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116113431A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021249525A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3179038A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021198706A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4103231A4 (en) | 2020-02-14 | 2024-03-27 | Geovax, Inc. | VACCINES AND THEIR USES TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV2 |
| CN113527444B (zh) * | 2020-04-13 | 2022-12-27 | 中国科学院微生物研究所 | 与新型冠状病毒的抗体有效结合的表位 |
| IL297419B2 (en) | 2020-04-22 | 2025-02-01 | BioNTech SE | Coronavirus vaccine |
| WO2021249011A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Hiv vaccine compositions, methods, and uses thereof |
| WO2021249116A1 (en) | 2020-06-10 | 2021-12-16 | Sichuan Clover Biopharmaceuticals, Inc. | Coronavirus vaccine compositions, methods, and uses thereof |
| WO2022041760A1 (en) | 2020-08-31 | 2022-03-03 | Sichuan Clover Biopharmaceuticals, Inc. | Methods and compositions for purification of trimeric fusion proteins |
| US20240293534A1 (en) * | 2021-06-14 | 2024-09-05 | Modernatx, Inc. | Coronavirus glycosylation variant vaccines |
| EP4183409A1 (en) * | 2021-11-17 | 2023-05-24 | Charité - Universitätsmedizin Berlin | Vaccine with improved immunogenicity against mutant coronaviruses |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
| JP2026508394A (ja) | 2023-03-03 | 2026-03-10 | ディオシンバックス リミテッド | コロナウイルスワクチン |
| EP4687969A1 (en) * | 2023-04-05 | 2026-02-11 | DIOSynVax Ltd | Coronavirus vaccines inducing broad immunity against variants |
| WO2025083402A1 (en) * | 2023-10-16 | 2025-04-24 | Diosynvax Ltd | Coronavirus vaccines |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG128680A1 (en) * | 2003-07-22 | 2007-01-30 | Crucell Holland Bv | Binding molecules against sars-coronavirus and uses thereof |
| WO2005077103A2 (en) * | 2004-02-12 | 2005-08-25 | Regents Of The University Of Colorado | Compositions and methods for modification and prevention of sars coronavirus infectivity |
| CN1884303A (zh) * | 2005-06-20 | 2006-12-27 | 中国医学科学院基础医学研究所 | SARS－CoV病毒结构蛋白的融合蛋白及其高量表达与纯化和用途 |
| CN102690336A (zh) * | 2012-06-11 | 2012-09-26 | 中国科学院武汉病毒研究所 | 蝙蝠sars样冠状病毒刺突蛋白免疫决定区及制备方法和用途 |
| WO2015143335A1 (en) * | 2014-03-20 | 2015-09-24 | The University Of North Carolina At Chapel Hill | Methods and compositions for chimeric coronavirus spike proteins |
| CN106928326B (zh) * | 2015-12-31 | 2019-12-24 | 中国科学院微生物研究所 | 一种基于二聚化的受体结合区亚单位的冠状病毒疫苗 |
| WO2019169120A1 (en) * | 2018-02-28 | 2019-09-06 | University Of Washington | Self-asssembling nanostructure vaccines |
| US11918643B2 (en) * | 2020-12-22 | 2024-03-05 | CureVac SE | RNA vaccine against SARS-CoV-2 variants |
-
2021
- 2021-04-01 US US17/916,369 patent/US20240285751A1/en active Pending
- 2021-04-01 CA CA3179038A patent/CA3179038A1/en active Pending
- 2021-04-01 CN CN202180039232.6A patent/CN116113431A/zh active Pending
- 2021-04-01 AU AU2021249525A patent/AU2021249525A1/en active Pending
- 2021-04-01 EP EP21717190.9A patent/EP4126033A2/en active Pending
- 2021-04-01 JP JP2022560285A patent/JP2023522156A/ja active Pending
- 2021-04-01 WO PCT/GB2021/050830 patent/WO2021198706A2/en not_active Ceased
-
2025
- 2025-09-29 JP JP2025162640A patent/JP2025184979A/ja active Pending